MANNITOL
Gastro-Intestinal Disorder
Pichamol Jirapinyo, MD, MPHSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Gastro-Intestinal Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Sucralose Pichamol Jirapinyo, MD, MPH | D | |
LACTULOSE Pichamol Jirapinyo, MD, MPH | D |
Same molecule, other indications
MANNITOL is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →